Search Results

Containing any of the words

Only of the type

SFDA Inspected 600 Food Establishments and Seized 176000 kilogram of Violated Food Stuff News

Two issues related to ParaPAC plus™ Model 300 and Model 310 Ventilator Medical Report

(SG-1904-22-H) Fresenius 5008 5008S Hemodialysis machines may fail Medical Report

A Randomized, double-blind, placebo-controlled, multicenter phase III study of RAD001 Adjuvant Therapy in Poor Risk with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching PlaceboAfter Patients Have Achieved Complete Response with First-line Rituximab Chemotherapy Drug Clinical Trial

(SG-2010-275-H) Software issues for the Infinity Acute Care System (IACS) and Standalone Infinity M540 patient monitor Medical Report

"SFDA" Withdraws and Suspends the Registration of (Omiz Plus 20mg, 40mg) Warnings

A Randomized, double-blind, placebo-controlled, multicenter phase III study of RAD001 Adjuvant Therapy in Poor Risk with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching PlaceboAfter Patients Have Achieved Complete Response with First-line Rituximab Chemotherapy Drug Clinical Trial

(SG-2111-364-H) Security Advisory regarding Philips MRI 1.5T and 3T release 5 Medical Report

A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects with Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease Drug Clinical Trial

AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS Drug Clinical Trial